Salmeterol (BioDeep_00000002022)

 

Secondary id: BioDeep_00000398456

human metabolite blood metabolite Chemicals and Drugs


代谢物信息卡片


4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol

化学式: C25H37NO4 (415.27224420000005)
中文名称: 沙美特罗
谱图信息: 最多检出来源 Homo sapiens(blood) 3.54%

分子结构信息

SMILES: C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
InChI: InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2

描述信息

Salmeterol is only found in individuals that have used or taken this drug. It is a long-acting beta2-adrenergic receptor agonist drug that is currently prescribed for the treatment of asthma and chronic obstructive pulmonary disease COPD. Salmeterols long, lipophilic side chain binds to exosites near beta(2)-receptors in the lungs and on bronchiolar smooth muscle, allowing the active portion of the molecule to remain at the receptor site, continually binding and releasing. Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
Salmeterol (GR33343X) is a potent and selective human β2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human β2, β1 and β3 adrenoceptors with pEC50s of 9.6, 6.1, and 5.9, respectively[1].

同义名列表

9 个代谢物同义名

4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol; Xinafoate, salmeterol; Salmeterol Xinafoate; GR-33343-X; Salmaterol; Salmeterol; GR-33343X; Serevent; GR33343X



数据库引用编号

18 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Hua Li, Tao Dong, Jinling Luan. Efficacy and safety of fluticasone propionate/salmeterol and fluticasone propionate monotherapy in step-up treatment of childhood asthma: A systematic review and meta-analysis. Heart & lung : the journal of critical care. 2023 Sep; 63(?):23-34. doi: 10.1016/j.hrtlng.2023.09.004. [PMID: 37740997]
  • Shendi Suryana, Mutakin Mutakin, Yudi Rosandi, Aliya Nur Hasanah. Molecular Dynamic Study of Mechanism Underlying Nature of Molecular Recognition and the Role of Crosslinker in the Synthesis of Salmeterol-Targeting Molecularly Imprinted Polymer for Analysis of Salmeterol Xinafoate in Biological Fluid. Molecules (Basel, Switzerland). 2022 Jun; 27(11):. doi: 10.3390/molecules27113619. [PMID: 35684555]
  • Glenn A Jacobson, Morten Hostrup. The salmeterol anomaly and the need for a urine threshold. Drug testing and analysis. 2022 Jun; 14(6):997-1003. doi: 10.1002/dta.2810. [PMID: 32314556]
  • Ahmed Samir, Hesham Salem, Mohammed Abdelkawy. Optimization of two charge transfer reactions for colorimetric determination of two beta 2 agonist drugs, salmeterol xinafoate and salbutamol, in pharmaceutical and biological samples. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2022 Mar; 269(?):120747. doi: 10.1016/j.saa.2021.120747. [PMID: 34952438]
  • Jiachun Li, Ziliang Huang, Keying Li, Xiaoyun Jian, Binghui Liang. Study on the Effect of Self-Made Lifei Dingchuan Decoction Combined with Western Medicine on Cough Variant Asthma. Computational and mathematical methods in medicine. 2022; 2022(?):9803552. doi: 10.1155/2022/9803552. [PMID: 36132547]
  • Muhammad Waqas Sadiq, Olaf Holz, Birthe D Ellinghusen, Cornelia Faulenbach, Meike Müller, Philipp Badorrek, Ulf G Eriksson, Markus Fridén, Stina Stomilovic, Anders J Lundqvist, Jens M Hohlfeld. Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation. British journal of pharmacology. 2021 11; 178(22):4440-4451. doi: 10.1111/bph.15621. [PMID: 34250588]
  • Fangyuan Chen, Qingya Shi, Fen Pei, Andreas Vogt, Rebecca A Porritt, Gustavo Garcia, Angela C Gomez, Mary Hongying Cheng, Mark E Schurdak, Bing Liu, Stephen Y Chan, Vaithilingaraja Arumugaswami, Andrew M Stern, D Lansing Taylor, Moshe Arditi, Ivet Bahar. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Molecular systems biology. 2021 08; 17(8):e10239. doi: 10.15252/msb.202110239. [PMID: 34339582]
  • Pär Ewing, Steven Oag, Anders Lundqvist, Stina Stomilovic, Ida Stellert, Malin Antonsson, Sandro Filipe Nunes, Patrik U Andersson, Ulrika Tehler, Carl Sjöberg, AnnaMaria Péterffy, Per Gerde. Airway Epithelial Lining Fluid and Plasma Pharmacokinetics of Inhaled Fluticasone Propionate and Salmeterol Xinafoate in Mechanically Ventilated Pigs. Journal of aerosol medicine and pulmonary drug delivery. 2021 08; 34(4):231-241. doi: 10.1089/jamp.2020.1637. [PMID: 33216656]
  • Panagiotis Sakellariou, Michael Petrou, Emmanouil Lyris, Maria Tsivou, Argyro Fragkaki, Polyxeni Kiousi, Yiannis S Angelis, Constantinos Pistos. Determination of salmeterol, α-hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS. Biomedical chromatography : BMC. 2021 Aug; 35(8):e5114. doi: 10.1002/bmc.5114. [PMID: 33720401]
  • Mahmoud A Omar, Dalia M Nagy, Hoda S Ahmed, Tamer Z Attia. Green spectrofluorimetric determination of salmeterol xinafoate in its pure forms, medicinal commercial formula, and human plasma: Application for stability studies. Luminescence : the journal of biological and chemical luminescence. 2021 Jun; 36(4):937-942. doi: 10.1002/bio.4019. [PMID: 33543552]
  • Ali Hatefi, Ahmad Zare Shahneh, Zarbakht Ansari Pirsaraie, Ali Mohammad Alizadeh, Mohammad Pouya Atashnak, Reza Masoudi, Frederic Pio. The stimulation and inhibition of beta-2 adrenergic receptor on the inflammatory responses of ovary and immune system in the aged laying hens. BMC veterinary research. 2021 May; 17(1):195. doi: 10.1186/s12917-021-02892-z. [PMID: 34022889]
  • Søren Jessen, Victoria Becker, Sebastian Rzeppa, Vibeke Backer, Kasper Høtoft Bengtsen, Ingunn Hullstein, Yvette Dehnes, Morten Hostrup. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control. Drug testing and analysis. 2021 Apr; 13(4):747-761. doi: 10.1002/dta.2978. [PMID: 33210444]
  • Fan Yi-Ling, Miao Qing, Liao Xing, Fan Chang-Zheng, Fan Mao-Rong, Cao Qing, Wang Ning, M A Qiu-Xiao, Hao Ya-Ni. [Systematic review and Meta-analysis on efficacy and safety of Liujunzi Decoction combined with Western medicine for stable chronic obstructive pulmonary disease]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 2020 Nov; 45(22):5331-5343. doi: 10.19540/j.cnki.cjcmm.20200720.501. [PMID: 33350192]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Mahmoud A Omar, Mohamed A Hammad, Mohamed Awad. Utility of Europium ion characteristic peak for quantitation of Fenoterol hydrobromide and Salmeterol xinafoate in different matrices; application to stability studies. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2019 Jun; 217(?):182-189. doi: 10.1016/j.saa.2019.03.072. [PMID: 30933783]
  • Gang Xing, Li Pan, Ce Yi, Xiaoran Li, Xinyue Ge, Ying Zhao, Yichuang Liu, Jinyan Li, Anthony Woo, Bin Lin, Yuyang Zhang, Maosheng Cheng. Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β2-adrenoceptor agonists. Bioorganic & medicinal chemistry. 2019 06; 27(12):2306-2314. doi: 10.1016/j.bmc.2018.10.043. [PMID: 30392952]
  • Bo Yu, Lusu Yao, Cuiqiao Liu, Lina Tang, Tao Xing. Upregulation of microRNA‑16 alters the response to inhaled β‑agonists in patients with asthma though modulating expression of ADRB2. Molecular medicine reports. 2019 May; 19(5):4027-4034. doi: 10.3892/mmr.2019.10097. [PMID: 30942450]
  • Erika Amore, Maria Letizia Manca, Maria Ferraro, Donatella Valenti, Valeria La Parola, Serena Di Vincenzo, Mark Gjomarkaj, Gaetano Giammona, Maria Luisa Bondì, Elisabetta Pace. Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment. International journal of pharmaceutics. 2019 May; 562(?):351-358. doi: 10.1016/j.ijpharm.2019.03.059. [PMID: 30935915]
  • Denise Wayne, Harald Iverson, Michael Gillespie, Edward Hellriegel, Calvin Small. Bioequivalence of fluticasone propionate and salmeterol (FS) given by the FS Spiromax® and Seretide Accuhaler® systems
. International journal of clinical pharmacology and therapeutics. 2019 Jan; 57(1):43-54. doi: 10.5414/cp203216. [PMID: 30431426]
  • Warisara Parichatikanond, Akiyuki Nishimura, Motohiro Nishida, Supachoke Mangmool. Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells. Journal of pharmacological sciences. 2018 Nov; 138(3):184-191. doi: 10.1016/j.jphs.2018.09.007. [PMID: 30322801]
  • Mohamed Awad, Mohamed A Hammad, Ahmed M Abdel-Megied, Mahmoud A Omar. Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma. Luminescence : the journal of biological and chemical luminescence. 2018 Aug; 33(5):913-918. doi: 10.1002/bio.3490. [PMID: 29708303]
  • Glenn A Jacobson, Sharanne Raidal, Kate Robson, Christian K Narkowicz, David S Nichols, E Haydn Walters. Salmeterol undergoes enantioselective bronchopulmonary distribution with receptor localisation a likely determinant of duration of action. Journal of pharmaceutical and biomedical analysis. 2018 May; 154(?):102-107. doi: 10.1016/j.jpba.2018.02.048. [PMID: 29544104]
  • S J Fenwick, P R Hincks, J P Scarth, M E Wieder, L L Hillyer, S W Paine. Detection and pharmacokinetics of salmeterol in thoroughbred horses following inhaled administration. Journal of veterinary pharmacology and therapeutics. 2017 Oct; 40(5):486-492. doi: 10.1111/jvp.12382. [PMID: 28097668]
  • Konstantina Soulele, Panos Macheras, Vangelis Karalis. Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers. Biopharmaceutics & drug disposition. 2017 Oct; 38(7):407-419. doi: 10.1002/bdd.2077. [PMID: 28374512]
  • Si Yan, Duncan E Shaw, Linhong Yang, David A Sandham, Mark P Healy, John Reilly, Bing Wang. Interactions between β2-Adrenoceptor Ligands and Membrane: Atomic-Level Insights from Magic-Angle Spinning NMR. Journal of medicinal chemistry. 2017 08; 60(16):6867-6879. doi: 10.1021/acs.jmedchem.7b00205. [PMID: 28703592]
  • Glenn A Jacobson, Morten Hostrup, Christian K Narkowicz, David S Nichols, E Haydn Walters. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control. Drug testing and analysis. 2017 Aug; 9(8):1262-1266. doi: 10.1002/dta.2131. [PMID: 28033454]
  • Glenn A Jacobson, J Paul Fawcett. Beta2-Agonist Doping Control and Optical Isomer Challenges. Sports medicine (Auckland, N.Z.). 2016 Dec; 46(12):1787-1795. doi: 10.1007/s40279-016-0547-4. [PMID: 27164986]
  • George Marshall. Falling up stairs. Australian family physician. 2016 Sep; 45(9):658-9. doi: NULL. [PMID: 27606369]
  • Anne Kotaniemi-Syrjänen, Weronika Delezuch, L Pekka Malmberg, Kari Punnonen, Irma H Matinlauri, Anna S Pelkonen, Mika J Mäkelä. Serum soluble TH cell activity markers and high-sensitivity C-reactive protein in multiple-trigger wheezers. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2016 08; 117(2):196-8. doi: 10.1016/j.anai.2016.05.022. [PMID: 27291855]
  • Vincent C H Chung, Xinyin Wu, Polly H X Ma, Robin S T Ho, Simon K Poon, David S Hui, Samuel Y S Wong, Justin C Y Wu. Chinese Herbal Medicine and Salmeterol and Fluticasone Propionate for Chronic Obstructive Pulmonary Disease: Systematic Review and Network Meta-Analysis. Medicine. 2016 May; 95(20):e3702. doi: 10.1097/md.0000000000003702. [PMID: 27196484]
  • Stephen T Horhota, Jan A van Noord, Cynthia B Verkleij, Loek J Bour, Ashish Sharma, Michael Trunk, Piet J G Cornelissen. In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers. The AAPS journal. 2015 Jul; 17(4):871-80. doi: 10.1208/s12248-015-9751-7. [PMID: 25794622]
  • Helge Haarmann, Cordula Mohrlang, Uta Tschiesner, David B Rubin, Thore Bornemann, Karin Rüter, Slavtcho Bonev, Tobias Raupach, Gerd Hasenfuß, Stefan Andreas. Inhaled β-agonist does not modify sympathetic activity in patients with COPD. BMC pulmonary medicine. 2015 Apr; 15(?):46. doi: 10.1186/s12890-015-0054-7. [PMID: 25924990]
  • Manal M Anwar, Radwan S El-Haggar, Wafaa A Zaghary. Salmeterol Xinafoate. Profiles of drug substances, excipients, and related methodology. 2015; 40(?):321-69. doi: 10.1016/bs.podrm.2015.02.002. [PMID: 26051688]
  • A Kalsen, M Hostrup, J Bangsbo, V Backer. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance. Scandinavian journal of medicine & science in sports. 2014 Oct; 24(5):814-22. doi: 10.1111/sms.12096. [PMID: 23834392]
  • Jian-hua Xu, Bin Xu, Yan-qing Deng. [Efficacy on chronic obstructive pulmonary disease at stable stage treated with cutting method and western medication]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion. 2014 Oct; 34(10):951-5. doi: NULL. [PMID: 25543420]
  • Nathan Rabinovitch, David T Mauger, Nichole Reisdorph, Ronina Covar, Jonathan Malka, Robert F Lemanske, Wayne J Morgan, Theresa W Guilbert, Robert S Zeiger, Leonard B Bacharier, Stanley J Szefler. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma. The Journal of allergy and clinical immunology. 2014 Feb; 133(2):350-6. doi: 10.1016/j.jaci.2013.07.039. [PMID: 24084071]
  • Huang-Pin Wu, Yu-Chih Liu, Shi-Chuan Lin, Ming-Yi Chien, Fang-Chun Liao, Shu-Chuan Chang, Wen-Bin Shieh. Comparison of respiratory parameters and plasma cytokine levels between treatment with Salmeterol/fluticasone and ipratropium/terbutaline/budesonide in mechanically ventilated COPD patients. Chang Gung medical journal. 2012 Sep; 35(5):373-81. doi: 10.4103/2319-4170.105481. [PMID: 23127342]
  • D J Nicholls, S Jordan, E Cadogan, M Lawson, R P Austin, S W Paine, P Gardiner, R Bonnert, S Connolly, A Young. Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action. Pulmonary pharmacology & therapeutics. 2012 Aug; 25(4):293-302. doi: 10.1016/j.pupt.2012.05.008. [PMID: 22659538]
  • Luigi Silvestro, Simona Rizea Savu, Simona Nicoleta Savu, Ariana Tudoroniu, Isabela Tarcomnicu. Development of a sensitive method for simultaneous determination of fluticasone propionate and salmeterol in plasma samples by liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC. 2012 May; 26(5):627-35. doi: 10.1002/bmc.1708. [PMID: 22577660]
  • Rhys M Jones, Anthony Harrison. A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats. Xenobiotica; the fate of foreign compounds in biological systems. 2012 Jan; 42(1):75-85. doi: 10.3109/00498254.2011.626465. [PMID: 22077102]
  • Robert J Walker, Nancy M Anderson, Suleiman Bahouth, Jena J Steinle. Silencing of insulin receptor substrate-1 increases cell death in retinal Müller cells. Molecular vision. 2012; 18(?):271-9. doi: NULL. [PMID: 22328823]
  • Robert J Walker, Nancy M Anderson, Youde Jiang, Suleiman Bahouth, Jena J Steinle. Role of β-adrenergic receptor regulation of TNF-α and insulin signaling in retinal Muller cells. Investigative ophthalmology & visual science. 2011 Dec; 52(13):9527-33. doi: 10.1167/iovs.11-8631. [PMID: 22110065]
  • Sonia Radice, Anna Milanesi, Stefania Antoniazzi, Valentina Perrone, Carla Carnovale, Emilio Clementi. A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol. European journal of clinical pharmacology. 2011 Nov; 67(11):1203-4. doi: 10.1007/s00228-011-1068-6. [PMID: 21638032]
  • Lester I Harrison, Christopher C Novak, Michael J Needham, Paul Ratner. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma. Journal of aerosol medicine and pulmonary drug delivery. 2011 Oct; 24(5):245-52. doi: 10.1089/jamp.2011.0884. [PMID: 21671752]
  • Koen Deventer, Oscar J Pozo, Frans T Delbeke, Peter Van Eenoo. Quantitative detection of inhaled salmeterol in human urine and relevance to doping control analysis. Therapeutic drug monitoring. 2011 Oct; 33(5):627-31. doi: 10.1097/ftd.0b013e318229c5f4. [PMID: 21912333]
  • P R Cooper, R C Kurten, J Zhang, D J Nicholls, I A Dainty, R A Panettieri. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms. British journal of pharmacology. 2011 Jun; 163(3):521-32. doi: 10.1111/j.1476-5381.2011.01257.x. [PMID: 21306583]
  • Paola Casarosa, Ines Kollak, Tobias Kiechle, Angela Ostermann, Andreas Schnapp, Ralf Kiesling, Michael Pieper, Peter Sieger, Florian Gantner. Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. The Journal of pharmacology and experimental therapeutics. 2011 Jun; 337(3):600-9. doi: 10.1124/jpet.111.179259. [PMID: 21357659]
  • Peter M A Calverley, Robert A Stockley, Terence A R Seemungal, Gerry Hagan, Lisa R Willits, John H Riley, Jadwiga A Wedzicha. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest. 2011 Mar; 139(3):505-512. doi: 10.1378/chest.09-2992. [PMID: 20576732]
  • Jian Xu, Rüdiger Nave, Gezim Lahu, Eric Derom, Hartmut Derendorf. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. Journal of clinical pharmacology. 2010 Oct; 50(10):1118-27. doi: 10.1177/0091270009354994. [PMID: 20150524]
  • Daniele Di Corcia, Veronica Morra, Marco Pazzi, Marco Vincenti. Simultaneous determination of beta2-agonists in human urine by fast-gas chromatography/mass spectrometry: method validation and clinical application. Biomedical chromatography : BMC. 2010 Apr; 24(4):358-66. doi: 10.1002/bmc.1300. [PMID: 19642085]
  • Dario Lombardi, Bernard Cuenoud, Stefanie D Krämer. Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties?. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2009 Dec; 38(5):533-47. doi: 10.1016/j.ejps.2009.10.001. [PMID: 19819331]
  • Thérèse S Lapperre, Jiska B Snoeck-Stroband, Margot M E Gosman, Désirée F Jansen, Annemarie van Schadewijk, Henk A Thiadens, Judith M Vonk, H Marike Boezen, Nick H T Ten Hacken, Jacob K Sont, Klaus F Rabe, Huib A M Kerstjens, Pieter S Hiemstra, Wim Timens, Dirkje S Postma, Peter J Sterk. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Annals of internal medicine. 2009 Oct; 151(8):517-27. doi: 10.7326/0003-4819-151-8-200910200-00004. [PMID: 19841453]
  • M Lommatzsch, Y Lindner, A Edner, K Bratke, M Kuepper, J C Virchow. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax. 2009 Sep; 64(9):763-9. doi: 10.1136/thx.2008.110916. [PMID: 19237390]
  • Arun Nair, Karine Clearie, Daniel Menzies, Karen Meldrum, Lesley McFarlane, Brian J Lipworth. A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. Pulmonary pharmacology & therapeutics. 2009 Aug; 22(4):305-10. doi: 10.1016/j.pupt.2009.02.001. [PMID: 19489129]
  • E Derom, R Louis, C Tiesler, R Engelstätter, J-M Kaufman, G F Joos. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. The European respiratory journal. 2009 Jun; 33(6):1277-86. doi: 10.1183/09031936.00079908. [PMID: 19164356]
  • M Degen, S Goulet, J Ferralli, M Roth, M Tamm, R Chiquet-Ehrismann. Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2009 May; 39(5):688-99. doi: 10.1111/j.1365-2222.2009.03220.x. [PMID: 19309351]
  • Terence L Fodey, Nuala M Greer, Steven R H Crooks. Antibody production: Low dose immunogen vs. low incorporation hapten using salmeterol as a model. Analytica chimica acta. 2009 Apr; 637(1-2):328-32. doi: 10.1016/j.aca.2008.09.025. [PMID: 19286047]
  • Dario Lombardi, Bernard Cuenoud, Heidi Wunderli-Allenspach, Stefanie D Krämer. Interaction kinetics of salmeterol with egg phosphatidylcholine liposomes by surface plasmon resonance. Analytical biochemistry. 2009 Feb; 385(2):215-23. doi: 10.1016/j.ab.2008.11.011. [PMID: 19084493]
  • Spencer J Carter, Vladimír Cápka. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2008 Dec; 876(2):163-9. doi: 10.1016/j.jchromb.2008.10.034. [PMID: 19010742]
  • Hans Jürgen Hoffmann, Lars Peter Nielsen, Henrik Harving, John H Heinig, Ronald Dahl. Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11. The clinical respiratory journal. 2008 Jul; 2(3):149-57. doi: 10.1111/j.1752-699x.2008.00054.x. [PMID: 20298323]
  • Ken M Kunisaki, Kathryn L Rice, Edward N Janoff, Thomas S Rector, Dennis E Niewoehner. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Therapeutic advances in respiratory disease. 2008 Apr; 2(2):55-64. doi: 10.1177/1753465808088902. [PMID: 19124359]
  • T Yamagata, T Hirano, H Sugiura, S Yanagisawa, T Ichikawa, K Ueshima, K Akamatsu, M Nakanishi, K Matsunaga, Y Minakata, M Ichinose. Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. Pulmonary pharmacology & therapeutics. 2008; 21(1):160-5. doi: 10.1016/j.pupt.2007.05.004. [PMID: 17632023]
  • Vladimír Cápka, Spencer J Carter. Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration levels. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Sep; 856(1-2):285-93. doi: 10.1016/j.jchromb.2007.06.010. [PMID: 17625989]
  • Mohammed A Alzoghaibi, Ahmed S Bahammam. Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting beta2 -agonists. Respirology (Carlton, Vic.). 2007 May; 12(3):439-42. doi: 10.1111/j.1440-1843.2007.01034.x. [PMID: 17539852]
  • Cristina Legido-Quigley, Norman W Smith. Short polystyrene monolith-fritted micro-liquid chromatography columns for rapid isocratic analysis of pharmaceuticals direct from plasma. Analytical and bioanalytical chemistry. 2006 Jun; 385(4):686-91. doi: 10.1007/s00216-006-0457-7. [PMID: 16741767]
  • J G Koopmans, R Lutter, H M Jansen, J S van der Zee. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Thorax. 2006 Apr; 61(4):306-12. doi: 10.1136/thx.2005.051292. [PMID: 16449264]
  • Julia G Koopmans, René Lutter, Henk M Jansen, Jaring S van der Zee. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. The Journal of allergy and clinical immunology. 2005 Nov; 116(5):1007-13. doi: 10.1016/j.jaci.2005.08.016. [PMID: 16275368]
  • Tom C Fardon, Daniel K C Lee, Melissa R Hodge, Brian J Lipworth. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2005 Sep; 95(3):259-65. doi: 10.1016/s1081-1206(10)61223-9. [PMID: 16200817]
  • Randolph Malone, Craig LaForce, Sai Nimmagadda, Lynne Schoaf, Karen House, Anna Ellsworth, Paul Dorinsky. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2005 Jul; 95(1):66-71. doi: 10.1016/s1081-1206(10)61190-8. [PMID: 16095144]
  • Rodger Kempsford, Malcolm Handel, Rashmi Mehta, Mariza De Silva, Peter Daley-Yates. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects. Respiratory medicine. 2005 Apr; 99 Suppl A(?):S11-9. doi: 10.1016/j.rmed.2004.11.005. [PMID: 15777604]
  • Alessandro Vatrella, Antonio Ponticiello, Girolamo Pelaia, Roberto Parrella, Mario Cazzola. Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. Pulmonary pharmacology & therapeutics. 2005; 18(2):89-92. doi: 10.1016/j.pupt.2004.09.033. [PMID: 15649850]
  • Daniel K C Lee, Caroline E Bates, Graeme P Currie, Louise M Cowan, Lesley C McFarlane, Brian J Lipworth. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2004 Sep; 93(3):253-8. doi: 10.1016/s1081-1206(10)61497-4. [PMID: 15478385]
  • Daniel F McAuley, James A Frank, Xiaohui Fang, Michael A Matthay. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Critical care medicine. 2004 Jul; 32(7):1470-6. doi: 10.1097/01.ccm.0000129489.34416.0e. [PMID: 15241090]
  • Petr Pohunek, Milan Matulka, Ondrej Rybnícek, Frantisek Kopriva, Helena Honomichlová, Tamara Svobodová. Dose-related efficacy and safety of formoterol (Oxis) Turbuhaler compared with salmeterol Diskhaler in children with asthma. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2004 Feb; 15(1):32-9. doi: 10.1046/j.0905-6157.2003.00096.x. [PMID: 14998380]
  • Tuan M Tran, Jackie Friedman, Eyad Qunaibi, Faiza Baameur, Robert H Moore, Richard B Clark. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Molecular pharmacology. 2004 Jan; 65(1):196-206. doi: 10.1124/mol.65.1.196. [PMID: 14722251]
  • F L Dente, E Bacci, M L Bartoli, S Cianchetti, A Di Franco, D Giannini, M Taccola, B Vagaggini, P L Paggiaro. One week treatment with salmeterol does not prevent early and late asthmatic responses and sputum eosinophilia induced by allergen challenge in asthmatics. Pulmonary pharmacology & therapeutics. 2004; 17(3):147-53. doi: 10.1016/j.pupt.2004.01.005. [PMID: 15123224]
  • Daniel K C Lee, Catherine M Jackson, Graeme P Currie, Wendy J Cockburn, Brian J Lipworth. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma. British journal of clinical pharmacology. 2003 Nov; 56(5):494-500. doi: 10.1046/j.1365-2125.2003.01887.x. [PMID: 14651722]
  • G P Currie, N J Syme-Grant, L C McFarlane, F A Carey, B J Lipworth. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma. Allergy. 2003 Jul; 58(7):602-7. doi: 10.1034/j.1398-9995.2003.00188.x. [PMID: 12823118]
  • Graeme P Currie, Suvi Stenback, Brian J Lipworth. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. British journal of clinical pharmacology. 2003 Jul; 56(1):11-7. doi: 10.1046/j.1365-2125.2003.01831.x. [PMID: 12848770]
  • Peter Calverley, Romain Pauwels, Jørgen Vestbo, Paul Jones, Neil Pride, Amund Gulsvik, Julie Anderson, Claire Maden. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (London, England). 2003 Feb; 361(9356):449-56. doi: 10.1016/s0140-6736(03)12459-2. [PMID: 12583942]
  • M Giroux, J Ferrières. Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist. The Journal of asthma : official journal of the Association for the Care of Asthma. 2003 Feb; 40(1):41-8. doi: 10.1081/jas-120017205. [PMID: 12699210]
  • P K Jeffery, P Venge, M J Gizycki, I Egerod, R Dahl, P Faurschou. Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. The European respiratory journal. 2002 Dec; 20(6):1378-85. doi: 10.1183/09031936.02.00542001. [PMID: 12503692]
  • Tien M H Ng, Mark A Munger, William L Lombardi, Tony H Doing, Darin T Ryujin, David C Young, Ralph A Lugo. Chronically inhaled salmeterol improves pulmonary function in heart failure. Journal of cardiovascular pharmacology. 2002 Jul; 40(1):140-5. doi: 10.1097/00005344-200207000-00017. [PMID: 12072587]
  • E Bacci, A Di Franco, M L Bartoli, S Carnevali, S Cianchetti, F L Dente, D Giannini, B Vagaggini, L Ruocco, P L Paggiaro. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. The European respiratory journal. 2002 Jul; 20(1):66-72. doi: 10.1183/09031936.02.00094202. [PMID: 12166584]
  • Stephen J Fowler, Graeme P Currie, Brian J Lipworth. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. The Journal of allergy and clinical immunology. 2002 Jun; 109(6):929-35. doi: 10.1067/mai.2002.123869. [PMID: 12063520]
  • Mario Cazzola, Renato Testi, Maria Gabriella Matera. Clinical pharmacokinetics of salmeterol. Clinical pharmacokinetics. 2002; 41(1):19-30. doi: 10.2165/00003088-200241010-00003. [PMID: 11825095]
  • P Van Eenoo, K Deventer, F T Delbeke. Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM. 2002; 16(18):1755-9. doi: 10.1002/rcm.786. [PMID: 12207363]
  • I V Medvedeva, S V Lapik, S A Gur'eva, I A Savina. [Clinical and biochemical aspects of flixotide administration in patients with moderate bronchial asthma]. Terapevticheskii arkhiv. 2002; 74(3):21-5. doi: ". [PMID: 11980114]
  • S Shrewsbury, C Hallett. Salmeterol 100 microg: an analysis of its tolerability in single- and chronic-dose studies. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2001 Dec; 87(6):465-73. doi: 10.1016/s1081-1206(10)62259-4. [PMID: 11770693]
  • D M McDonald. Angiogenesis and remodeling of airway vasculature in chronic inflammation. American journal of respiratory and critical care medicine. 2001 Nov; 164(10 Pt 2):S39-45. doi: 10.1164/ajrccm.164.supplement_2.2106065. [PMID: 11734465]
  • R L ZuWallack, D A Mahler, D Reilly, N Church, A Emmett, K Rickard, K Knobil. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest. 2001 Jun; 119(6):1661-70. doi: 10.1378/chest.119.6.1661. [PMID: 11399688]
  • I Vachier, C Chavis, M Majori, M Farce, J Bousquet, P Godard, P Chanez. Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma. The Journal of allergy and clinical immunology. 2001 May; 107(5):824-31. doi: 10.1067/mai.2001.113868. [PMID: 11344349]
  • M L Kwan, A D Gómez, P Baluk, H Hashizume, D M McDonald. Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. American journal of physiology. Lung cellular and molecular physiology. 2001 Feb; 280(2):L286-97. doi: 10.1152/ajplung.2001.280.2.l286. [PMID: 11159008]
  • E D Bateman, V Silins, M Bogolubov. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma. Respiratory medicine. 2001 Feb; 95(2):136-46. doi: 10.1053/rmed.2000.1008. [PMID: 11217910]
  • S Kirby, C Falcoz, M J Daniel, S Milleri, L Squassante, L Ziviani, G P Ventresca. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. European journal of clinical pharmacology. 2001 Jan; 56(11):781-91. doi: 10.1007/s002280000233. [PMID: 11294367]
  • B E Del Río-Navarro, J J Sienra-Monge, M Alvarez-Amador, N Reyes-Ruiz, A Arévalo-Salas, A Berber. Serum potassium levels, CPK-MB and ECG in children suffering asthma treated with beclomethasone or beclomethasone-salmeterol. Allergologia et immunopathologia. 2001 Jan; 29(1):16-21. doi: 10.1016/s0301-0546(01)79010-6. [PMID: 11449530]
  • J R Fozard, H Buescher. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey. Pulmonary pharmacology & therapeutics. 2001; 14(4):289-95. doi: 10.1006/pupt.2001.0295. [PMID: 11440557]
  • D R Taylor, R J Hancox, W McRae, J O Cowan, E M Flannery, C R McLachlan, G P Herbison. The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist. The Journal of asthma : official journal of the Association for the Care of Asthma. 2000 Dec; 37(8):691-700. doi: 10.3109/02770900009087308. [PMID: 11192234]
  • J A Frank, Y Wang, O Osorio, M A Matthay. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. Journal of applied physiology (Bethesda, Md. : 1985). 2000 Oct; 89(4):1255-65. doi: 10.1152/jappl.2000.89.4.1255. [PMID: 11007557]